FDA invokes GMP authority to propose unit-dose packaging for iron-containing supplements.
This article was originally published in The Tan Sheet
Executive Summary
FDA INVOKES GMP AUTHORITY FOR IRON SUPPLEMENT UNIT-DOSE PACKAGING proposal in a "supplemental" proposed rule published in the Feb. 16 Federal Register. The notice provides a legal basis for an October 1994 proposed rule that requires child-resistant unit-dose packaging on all products (drugs and dietary supplements) that contain 30 mg or more iron per dosage unit. The supplemental rule, FDA explained, "set[s] forth [the agency's] legal authority" for the proposed rule after the passage of the Dietary Supplement Health & Education Act.
You may also be interested in...
Iron-Containing Supplement, Drug Unit-Dose Packaging Rule Invalid – Court
FDA's reliance on current Good Manufacturing Practice regulations under the FD&C Act to justify requirement of unit-dose packaging for iron-containing dietary supplements and drugs is "misplaced," a New York federal appeals court concludes
Iron-Containing Supplement, Drug Unit-Dose Packaging Rule Invalid – Court
FDA's reliance on current Good Manufacturing Practice regulations under the FD&C Act to justify requirement of unit-dose packaging for iron-containing dietary supplements and drugs is "misplaced," a New York federal appeals court concludes
Iron-Containing Supplement, Drug Unit-Dose Packaging Rule Invalid – Court
FDA's reliance on current Good Manufacturing Practice regulations under the FD&C Act to justify requirement of unit-dose packaging for iron-containing dietary supplements and drugs is "misplaced," a New York federal appeals court concludes